IE37370L - 2, 6-diamino-dihydropyridines - Google Patents
2, 6-diamino-dihydropyridinesInfo
- Publication number
- IE37370L IE37370L IE730346A IE34673A IE37370L IE 37370 L IE37370 L IE 37370L IE 730346 A IE730346 A IE 730346A IE 34673 A IE34673 A IE 34673A IE 37370 L IE37370 L IE 37370L
- Authority
- IE
- Ireland
- Prior art keywords
- alkyl
- radical
- chain
- march
- alkoxy
- Prior art date
Links
- XNJATKPGORTUCP-UHFFFAOYSA-N 1,2-dihydropyridine-2,6-diamine Chemical class NC1NC(N)=CC=C1 XNJATKPGORTUCP-UHFFFAOYSA-N 0.000 title 1
- -1 cyclic hydrocarbon radical Chemical class 0.000 abstract 4
- 150000003254 radicals Chemical class 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 150000001409 amidines Chemical class 0.000 abstract 1
- 239000002220 antihypertensive agent Substances 0.000 abstract 1
- 229940030600 antihypertensive agent Drugs 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 150000005840 aryl radicals Chemical class 0.000 abstract 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- MLIREBYILWEBDM-UHFFFAOYSA-N cyanoacetic acid Chemical class OC(=O)CC#N MLIREBYILWEBDM-UHFFFAOYSA-N 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 1
- 125000004925 dihydropyridyl group Chemical group N1(CC=CC=C1)* 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000005956 isoquinolyl group Chemical group 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000000714 pyrimidinyl group Chemical group 0.000 abstract 1
- 125000005493 quinolyl group Chemical group 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
1379005 Dihydropyridines BAYER AG 6 March 1973 [6 March 1972 12 Sept 1972] 10759/73 Heading C2C The invention comprises novel compounds of the tautomeric formulae in which R is a saturated or unsaturated, straight-chain, branched or cyclic hydrocarbon radical, or an aryl radical optionally carrying 1, 2 or 3 identical or different substitutents selected from aryl, alkyl, alkoxy, azido, halogen, nitro, cyano, trifluoromethyl, carbalkoxy and -SO n -Alkyl (in which n = 0, 1 or 2) radicals, or a naphthyl, quinolyl, isoquinolyl, pyridyl, pyrimidyl, thenyl, furyl or pyrryl radical optionally carrying at least one substituent selected from alkyl, alkoxy and halogen radicals; and R<SP>1</SP> and R<SP>2</SP> which can be the same or different, are each a radical -OR<SP>1</SP> in which R<SP>1</SP> is a straight-chain, branched or cyclic, saturated or unsaturated aliphatic hydrocarbon radical the carbon chain of which may be interrupted by 1 or 2 oxygen atoms, or an amino, alkylamino, or dialkylamino group. They are made by reacting an amidine of formula with RCHO or with an ylidene cyanoacetic acid derivative of formula R<SP>1</SP>OC-C(.CN)(:CHR). Pharmaceutical preparations especially useful as coronary and anti-hypertensive agents contain the novel compounds as active ingredients; standard administration forms are described.
[GB1379005A]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2210687A DE2210687C3 (en) | 1972-03-06 | 1972-03-06 | 2,6-diamino-3,5-diethoxycarbonyldihydropyridines, process for their preparation and pharmaceuticals containing them |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE37370L true IE37370L (en) | 1973-09-06 |
| IE37370B1 IE37370B1 (en) | 1977-07-06 |
Family
ID=5838037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE346/73A IE37370B1 (en) | 1972-03-06 | 1973-03-05 | New 2,6-diamino-dihydropyridines their production and their medicinal use |
Country Status (24)
| Country | Link |
|---|---|
| JP (2) | JPS5626659B2 (en) |
| KR (1) | KR780000119B1 (en) |
| AT (3) | AT327904B (en) |
| BE (1) | BE796279A (en) |
| BG (2) | BG22815A3 (en) |
| CA (1) | CA988524A (en) |
| CH (2) | CH577473A5 (en) |
| CS (2) | CS182781B2 (en) |
| DD (1) | DD106833A5 (en) |
| DE (1) | DE2210687C3 (en) |
| DK (1) | DK136061C (en) |
| ES (1) | ES412323A1 (en) |
| FI (1) | FI55996C (en) |
| FR (1) | FR2181789B1 (en) |
| GB (1) | GB1379005A (en) |
| HU (1) | HU167089B (en) |
| IE (1) | IE37370B1 (en) |
| IL (1) | IL41664A (en) |
| LU (1) | LU67147A1 (en) |
| NL (1) | NL7303137A (en) |
| PL (2) | PL92078B1 (en) |
| RO (2) | RO63068A (en) |
| SE (1) | SE384208B (en) |
| ZA (1) | ZA731501B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2210687C3 (en) * | 1972-03-06 | 1981-09-24 | Bayer Ag, 5090 Leverkusen | 2,6-diamino-3,5-diethoxycarbonyldihydropyridines, process for their preparation and pharmaceuticals containing them |
| DE2406198C2 (en) * | 1974-02-09 | 1983-12-15 | Bayer Ag, 5090 Leverkusen | Process for the preparation of new 2-amino-6-dialkylamino-dihydropyridines |
| JPS5922593U (en) * | 1982-08-03 | 1984-02-10 | 日本マランツ株式会社 | Horn mounting structure for headphone |
| JPS5922594U (en) * | 1982-08-03 | 1984-02-10 | 日本マランツ株式会社 | earplug type headphone |
| JPS6282898A (en) * | 1985-10-08 | 1987-04-16 | Matsushita Electric Ind Co Ltd | headphone |
| JPS6293060U (en) * | 1985-11-28 | 1987-06-13 | ||
| KR20230144524A (en) * | 2020-11-30 | 2023-10-16 | 난양 테크놀러지컬 유니버시티 | A potent and selective inhibitor of the calcium-activated potassium channel, Kca3.1, for use as a platform therapeutic. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3855231A (en) * | 1972-03-06 | 1974-12-17 | Bayer Ag | 2,6-diamino-1,4-dihydropyridine derivatives |
| DE2210687C3 (en) * | 1972-03-06 | 1981-09-24 | Bayer Ag, 5090 Leverkusen | 2,6-diamino-3,5-diethoxycarbonyldihydropyridines, process for their preparation and pharmaceuticals containing them |
| DE2406198C2 (en) * | 1974-02-09 | 1983-12-15 | Bayer Ag, 5090 Leverkusen | Process for the preparation of new 2-amino-6-dialkylamino-dihydropyridines |
-
1972
- 1972-03-06 DE DE2210687A patent/DE2210687C3/en not_active Expired
-
1973
- 1973-02-13 RO RO7300082647A patent/RO63068A/ro unknown
- 1973-02-13 RO RO73832A patent/RO61192A/ro unknown
- 1973-02-26 DD DD169048A patent/DD106833A5/xx unknown
- 1973-02-28 BG BG022858A patent/BG22815A3/en unknown
- 1973-02-28 BG BG024472A patent/BG20583A3/en unknown
- 1973-03-02 JP JP2445273A patent/JPS5626659B2/ja not_active Expired
- 1973-03-02 LU LU67147A patent/LU67147A1/xx unknown
- 1973-03-02 FI FI657/73A patent/FI55996C/en active
- 1973-03-02 CH CH220176A patent/CH577473A5/xx not_active IP Right Cessation
- 1973-03-02 CH CH313273A patent/CH580589A5/xx not_active IP Right Cessation
- 1973-03-02 IL IL7341664A patent/IL41664A/en unknown
- 1973-03-03 PL PL1973182270A patent/PL92078B1/pl unknown
- 1973-03-03 PL PL1973161010A patent/PL89256B1/pl unknown
- 1973-03-05 DK DK118073A patent/DK136061C/en active
- 1973-03-05 IE IE346/73A patent/IE37370B1/en unknown
- 1973-03-05 BE BE128374A patent/BE796279A/en not_active IP Right Cessation
- 1973-03-05 SE SE7303021A patent/SE384208B/en unknown
- 1973-03-05 ZA ZA731501A patent/ZA731501B/en unknown
- 1973-03-05 ES ES412323A patent/ES412323A1/en not_active Expired
- 1973-03-05 CA CA165,209A patent/CA988524A/en not_active Expired
- 1973-03-05 KR KR7300356A patent/KR780000119B1/en not_active Expired
- 1973-03-06 GB GB1075973A patent/GB1379005A/en not_active Expired
- 1973-03-06 CS CS7300001593A patent/CS182781B2/en unknown
- 1973-03-06 NL NL7303137A patent/NL7303137A/xx not_active Application Discontinuation
- 1973-03-06 AT AT925774*7A patent/AT327904B/en not_active IP Right Cessation
- 1973-03-06 FR FR7307923A patent/FR2181789B1/fr not_active Expired
- 1973-03-06 AT AT925774A patent/ATA925774A/en unknown
- 1973-03-06 CS CS7500003602A patent/CS182792B2/en unknown
- 1973-03-06 HU HUBA2892A patent/HU167089B/hu unknown
- 1973-03-06 AT AT197373A patent/AT324338B/en not_active IP Right Cessation
-
1980
- 1980-12-27 JP JP55185147A patent/JPS5911584B2/en not_active Expired
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1384031A (en) | N-substituted dihydropyridine compounds their production and their medicinal use | |
| IE37538L (en) | 1, 4-dihydropyridine carboxylic acid compounds | |
| FI900307A0 (en) | Process for the preparation of therapeutically active 3- [3-oxo- (2,3) -dihydropyridazin-6-yl] -2-phenylpyrazolo [1,5-a] pyridine derivatives | |
| GB1477114A (en) | 1,4-dihydropyridinecarboxylic acid aralkyl esters processes for their preparation and their use as medicaments | |
| RU93035829A (en) | Aminoquinolone derivatives substituted by an aryl or heteroaromatic group and anti-HIV drugs | |
| UA41244C2 (en) | Derivatives of propene acid having fungicide activity | |
| IE36947L (en) | 14 - dihydropyridinecarboxycic acid esters | |
| GB1384504A (en) | Bridgeheadheterocyclic compounds their production and their medicinal use | |
| GB1369401A (en) | Process for the manufacture of 2-amino-1,4-dihydropyridines and their use as coronary agents | |
| GB1389509A (en) | Dihydropyridinepolyesters their production and their medicinal use | |
| IE42668L (en) | Salicylanilide derivatives | |
| IE37370B1 (en) | New 2,6-diamino-dihydropyridines their production and their medicinal use | |
| ATE39357T1 (en) | DERIVATIVES OF GRISEOLIC ACID AND THEIR USE. | |
| KR880012586A (en) | New pyridyl and pyrimidyl derivatives | |
| GB1389504A (en) | 2-amino-1,4-dihydropyridines their production and their medicinal use | |
| KR880009021A (en) | Pyrazolo [3,4-d] pyrimidine derivatives, compositions and uses thereof | |
| EP0191724A3 (en) | 1,4-dihydropyridine derivatives, their preparation and pharmaceutical compositions containing them | |
| IT1216104B (en) | PEPTIDES WITH PHARMACEUTICAL ACTIVITY. | |
| IE38141L (en) | 3, 4-dihydropyridones. | |
| IE38064L (en) | 2-amino-4h-pyran derivatives. | |
| IE37367L (en) | 2-amino-4, 5-dihydropyridine-3, 5-dicarboxylic acid esters | |
| PT84101A (en) | NOVEL AMIDES SUBSTITUTED FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| GB1173304A (en) | A Process for the Manufacture of Benzoxadiaz[4,1,5]Ocines | |
| GB1271147A (en) | Novel 2,3-disubstituted quinazolinone derivatives | |
| GB1368546A (en) | Partially hydrogenated benzoquinolizines their manufacture and their medicinal use |